Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients

Clinica Chimica Acta

Volumn 383, Issue 1-2, 2007, Pages 147-152

  Giannelli, Gianluigi ^a   Fransvea, Emilia ^a   Trerotoli, Paolo ^a   Beaugrand, Michel ^b   Marinosci, Felice ^a   Lupo, Luigi ^a   Nkontchou, Gisele ^b   Dentico, Pietro ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

AFP; Biomarkers; Diagnosis; HCC; SCCA

Indexed keywords

ALPHA FETOPROTEIN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VALIDATION STUDY;

AGED; ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC TECHNIQUES AND PROCEDURES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 34347334468     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.05.014     Document Type: Article

References (19)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
3. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
4. Sherman M., and Klein A. AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. Hepatology 40 (2004) 1465-1473
5. Marrero J.A., and Lok A.S. Newer markers for hepatocellular carcinoma. Gastroenterology 127 (2004) S113-S119
6. Giannelli G., and Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis 38 (2006) 854-859
7. Pontisso P., Calabrese F., Benvegnu L., et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 90 (2004) 833-837
8. Giannelli G., Marinosci F., Sgarra C., Lupo L., Dentico P., and Antonaci S. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 116 (2005) 579-583
9. Beneduce L., Castaldi F., Marino M., et al. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer 103 (2005) 2558-2565
10. Beneduce L., Castaldi F., Marino M., et al. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes. Int J Biol Markers 19 (2004) 155-159
11. Velazquez R.F., Rodriguez M., Navascues C.A., et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37 (2003) 520-527
12. Koike Y., Shiratori Y., Sato S., et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91 (2001) 561-569
13. Marrero J.A., Romano P.R., Nikolaeva O., et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43 (2005) 1007-1012
14. Okuda K., Tanaka M., Kanazawa N., et al. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein. Int J Oncol 14 (1999) 265-271
15. Suminami Y., Kishi F., Sekiguchi K., and Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181 (1991) 51-58
16. Kato H., Suehiro Y., Morioka H., et al. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies. Jpn J Cancer Res 78 (1987) 1246-1250
17. Kato H., and Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40 (1977) 1621-1628
18. Giannelli G., Marinosci F., Trerotoli P., et al. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC. Int J Cancer 117 (2005) 506-509
19. Pontisso P., Quarta S., Caberlotto C., et al. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Int J Cancer 119 (2006) 735-740